跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
POMALIDOMIDE SANDOZ pomalidomide 2 mg capsule blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
POMALIDOMIDE SANDOZ pomalidomide 2 mg capsule blister pack
Approved
STANDARD
POMALIDOMIDE SANDOZ pomalidomide 2 mg capsule blister pack
Sandoz Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
46a14210745aed97
Company
Sandoz Pty Ltd
Type
Standard
Approval Details
Approval Id
46a14210745aed97
Product Name
POMALIDOMIDE SANDOZ pomalidomide 2 mg capsule blister pack
Artg Id
352570
Artg Name
POMALIDOMIDE SANDOZ pomalidomide 2 mg capsule blister pack
Sponsor
Sandoz Pty Ltd
Company Detail Path
/organization/sandoz-pty-ltd
Artg Date
2022-06-02
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/192a74896232420467dca6664dc90fe3.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/afbcbebe63749bf87d486384d8fd17c2.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
46a14210745aed97
Type
Standard
Back to TGA Approvals